Antilipolytic and antilipogenic effects of the CPT-1b inhibitor oxfenicine in the white adipose tissue of rats.

about

Examination of carnitine palmitoyltransferase 1 abundance in white adipose tissue: implications in obesity research.Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.

P2860

Q46399354-AC85B947-8DCB-4FC9-952F-6EB6FA595429 Q49247394-3085BFF6-331C-4AC6-91D7-F61C3963F027

P2860

Antilipolytic and antilipogenic effects of the CPT-1b inhibitor oxfenicine in the white adipose tissue of rats.

Item

http://www.wikidata.org/entity/Q41630738

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Antilipolytic and antilipogeni ...... white adipose tissue of rats.

@en

type

Item

label

Antilipolytic and antilipogeni ...... white adipose tissue of rats.

@en

prefLabel

Antilipolytic and antilipogeni ...... white adipose tissue of rats.

@en

P1476

Antilipolytic and antilipogeni ...... white adipose tissue of rats.

@en

P2093

Abinas Uthayakumar

http://www.w3.org/2001/XMLSchema#string

Arta Mohasses

http://www.w3.org/2001/XMLSchema#string

Diane M Sepa-Kishi

http://www.w3.org/2001/XMLSchema#string

Michelle V Wu

http://www.w3.org/2001/XMLSchema#string

Rolando B Ceddia

http://www.w3.org/2001/XMLSchema#string

P2860

Adipose triglyceride lipase-mediated lipolysis of cellular fat stores is activated by CGI-58 and defective in Chanarin-Dorfman Syndrome

Mechanisms and metabolic implications of regional differences among fat depots

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

Present state of alpha- and beta-adrenergic drugs I. The adrenergic receptor.

Measurements of glucose conversion to its metabolites.

Cellularity measurements.

Relationship between insulin-mediated glucose disposal and lipid metabolism in man.

Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome.

Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity.

Impaired mitochondrial fat oxidation induces adaptive remodeling of muscle metabolism.

P304

R779-R787

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPREGU.00243.2016

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27558315

http://www.w3.org/2001/XMLSchema#string

P932

5142162

http://www.w3.org/2001/XMLSchema#string

Antilipolytic and antilipogenic effects of the CPT-1b inhibitor oxfenicine in the white adipose tissue of rats.

about

P2860

P2860

Antilipolytic and antilipogenic effects of the CPT-1b inhibitor oxfenicine in the white adipose tissue of rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932